CellMax Life Earns FDA Breakthrough Device Designation for Colon Cancer & Pre-Cancerous Adenomas Screening Blood Test
25 août 2021 06h00 HE
|
CellMax Life
SUNNYVALE, Calif., Aug. 25, 2021 (GLOBE NEWSWIRE) -- CellMax Life, a molecular diagnostics company, announced today that its FirstSight™ pre-cancer and cancer detection blood test has received...